Lexicon Pharmaceuticals Inc (LXRX)
0.8595
-0.07
(-7.57%)
USD |
NASDAQ |
Jan 08, 16:00
0.8411
-0.02
(-2.14%)
After-Hours: 20:00
Lexicon Pharmaceuticals SG&A Expense (Quarterly): 39.59M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Viatris Inc | 1.003B |
| Halozyme Therapeutics Inc | 41.24M |
| Perspective Therapeutics Inc | 6.975M |
| Quanterix Corp | 23.80M |
| Autonomix Medical Inc | 1.662M |